我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

失功能性高密度脂蛋白致动脉粥样硬化的机制(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2012年第3期
页码:
416-418
栏目:
综述
出版日期:
2012-06-25

文章信息/Info

Title:
Mechanism of dysfunctional high-density lipoprotein-induced atherosclerosis
作者:
张 月1马小川1张 涛1姚 亮2
(1.延安大学附属医院心内科一病区,陕西 延安 716000;2.陕西省理工学校,陕西 西安 710000)
Author(s):
ZHANG Yue1 MA Xiao-chuan1 ZHANG Tao1 YAO Liang2
(1.First Department of Cardiology, Affiliated Hospital to Yan’an University, Yan’an 716000, Shaanxi, China; 2.Shaanxi Polytechnic School, Xi’an 710000, Shaanxi, China)
关键词:
高密度脂蛋白动脉粥样硬化机制
Keywords:
high-density lipoprotein atherosclerosis mechanism
分类号:
Q513.5
DOI:
-
文献标识码:
A
摘要:
近几年的一些研究认为,在一些疾病中(如Ⅱ型糖尿病及代谢综合征及系统性红斑狼疮等),一直被誉为“好脂蛋白”的高密度脂蛋白(HDL)不仅血浆水平降低,其结构还会发生改变进而功能逆转,加速了动脉粥样硬化(AS)的发展,提高心血管病的风险。因此,阐明失功能性HDL在疾病状态中致AS的机制将有助于心血管疾病的预防与治疗,本文就功能性和失能性HDL的抗AS作用进行了综述。
Abstract:
In recent years it has been found that high-density lipoprotein, hailed as “good LDL” in some studies, is reduced and its structure changes in some diseases such as type 2 diabetes, metabolic syndrome, and systemic lupus erythematosus. The reversed function accelerates the development of atherosclerosis and enhances risks of cardiovascular disease. This paper reviewed the anti-atherosclerosis mechanism of functional and dysfunctional high-density lipoprotein.

参考文献/References

[1]Satoh H,Tomita K,Fujii S,et al.Lower high-den- sity lipoproteincholesterol is a signific- ant and independent risk for coronary artery disease in Japanese men[J].J Atheroscler Thomb,2009,16(6):792-798.

[2]汪克纯,王 曦,张冬颖,等.血浆高密度脂蛋白胆固醇水平与选择性冠状动脉造影患者冠状动脉病变的关系[J].中国老年学杂志,2010,30(21):3070-3071.

[3]Yasuda T,Ishida T,Rader DJ.Update on the role of endothelial lipase inhigh-density lipoprotein met -abolism, reverse cholesterol transport, and atherosc lerosis[J].Circ J,2010,74(11):2263-2270.

[4]陈国良,刘立伟,谢 爽,等. 高密度脂蛋白胆固醇代谢及其对冠心病影响的研究进展[J].心血管病进展,2010,31(3):360-363.

[5]Mackness B,Mackness M.Anti-inflammatory properties of paraoxonase-1 in Atheros clerosis[J].Adv Exp Med Biol,2010,660:143-151.

[6]Witting PK,Song C,Hsu K,et al.The acutephase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein[J].Free Radic Biol Med,2011,51(7):1390-1398.

[7]Hahn BH,Lourenco EV,McMahon M,et al.Proinfla mmatory high-density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and lep t-in[J].Lupus,2010,19(8):913-917.

[8]Skaggs BJ,Hahn BH,Sahakian L,et al.Dysfunctional,proinflammatory HDL directly upregulates monocyte PDGFRβ,chemotaxis and TNFα production[J].Clin Immunol,2010,137(1):147-156.

[9]McGillicuddy FC, de la Llera Moya M,Hinkle CC,et al.Inflammation impairs reverse cholesterol transport in vivo[J]. Circulation,2009,119(8):1135-1145.

[10]Shao B,Heinecke JW.Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway[J].J Proteomics,2011,74(11):2289-2299.

[11]Bellanger N,Orsoni A,Julia Z,et al.Ather- oprotective reverse cholesterol transport pathway is defective in familial hype rchole ster- olemia[J].Arterioscler Thromb Vasc Biol,2011,31(7):1675-1681.

[12]Sorci-Thomas MG,Zabalawi M,Bharadwaj MS,et al.Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperli pidemic mice[J].Biochim Biophys Acta,2012,1821(3):502-512.

[13]Thorne RF,Mhaidat NM,Ralston KJ,et al.CD36 is a receptor for oxidized high density lipo- protein:implications for the development of atherosclerosis[J].FEBS Lett,2007,581(6):1227-1232.

[14]Ren J,Jin W,Chen H.oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms[J].Mol Cell Biochem,2010,342(1-2):171-181.

[15]Smith JD.Myeloperoxidase,inflammation,and dysfunctional high-density lipoprotein[J].J Clin Lipidol,2010,4(5):382-388.

[16]Undurti A,Huang Y,Lupica JA,et al.Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle[J].J Biol Chem,2009,284(45):30825-30835.

[17]Valiyaveettil M,Kar N,Ashraf MZ,et al.Oxidized high-density lipoprotein inhibits platelet activation and aggregation viascavenger receptor BI[J].Blood, 2008,111(4):1962-1971.

备注/Memo

备注/Memo:
收稿日期:2011-10-27.通讯作者:马小川,主任医师,主要从事介入心脏病学研究 Email:maxch1964@163.com 作者简介:张月,硕士生 Email:32381217@qq.com
更新日期/Last Update: 2012-05-02